Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Aug 2;11:15622. doi: 10.1038/s41598-021-94875-1

Optimal solution of the fractional order breast cancer competition model

H Hassani 1, J A Tenreiro Machado 2, Z Avazzadeh 3,, E Safari 4, S Mehrabi 5
PMCID: PMC8329307  PMID: 34341390

Abstract

In this article, a fractional order breast cancer competition model (F-BCCM) under the Caputo fractional derivative is analyzed. A new set of basis functions, namely the generalized shifted Legendre polynomials, is proposed to deal with the solutions of F-BCCM. The F-BCCM describes the dynamics involving a variety of cancer factors, such as the stem, tumor and healthy cells, as well as the effects of excess estrogen and the body’s natural immune response on the cell populations. After combining the operational matrices with the Lagrange multipliers technique we obtain an optimization method for solving the F-BCCM whose convergence is investigated. Several examples show that a few number of basis functions lead to the satisfactory results. In fact, numerical experiments not only confirm the accuracy but also the practicability and computational efficiency of the devised technique.

Subject terms: Breast cancer, Mathematics and computing

Introduction

Cancer is one of the most ubiquitous genetic diseases1,2. It is known that the disease arises because of mutations in the cancer susceptibility genes3. In order to understand the mechanism of human breast cancer various methods have been advanced. Loeb et al.4 proposed the existance of a mutator phenotype that acts as a mechanism in tumor processes. Tomlinson and Bordmer57 investigated the mutator phenotype hypothesis and discovered that the selection for clonal expansion of intermediate cells.

Mathematical models describe the fundamental principles of the population genetics and evolutionary mechanisms that govern tumor initiation and progression in cancer biology8,9. It was discovered that the dynamics of tumorgenesis is determined by a number of factors including mutation, selection, and tissue types1013. It is also known that an increase in the postmenopausal and estrogen receptor-positive cases may increase the rate of breast cancer among women14. Several attempts have been made for the description of breast cancer in a variaty of perspectives. Enderling et al.15 presented a model of the growth and invasion of a solid tumour in a domain of breast tissue and proposed a scheme for the surgery and radiation treatment of the tumour. Enderling et al.16 applied surgery, as well as adjuvant external beam and targeted intraoperative radiotherapies, and used a model to identify different sources of local recurrence to analyse their prevention. Simmons et al.17 presented a brief overview of breast cancer, focussing on its heterogeneity and the role of modelling and simulation in teasing apart the underlying biophysical processes. Nave et al.18 described the treatment of breast cancer by a model involving nonlinear ordinary differential equations with a hidden hierarchy. Interested readers can follow also some recent works in1925.

Fractional calculus is one of the most intensively developing branches of mathematical analysis and deals with derivatives and integrals of arbitrary order26. Fractional differential equations have motivated considerable attention in several branches of science2732. In applied sciences, memory properties have been widely found in many complex phenomena. The use of fractional derivatives, instead of integer ones, can potencially lead to better results since one has an extra degree of freedom. Indeed, due to their intrinsic nonlocal property, the fractional differential equations have been successfully used to describe phenomena or processes with memory and hereditary properties in physics, chemistry, biology, and economy. Readers can refer to33,34. Fractional calculus is an excellent tool for modeling materials and processes with memory and hereditary properties and, in particular, electrochemical problems35. Fractional differentiation and integration operators are also used for generalizing the diffusion and wave equations36,37 or, more recently, of the temperature field problem in oil strata38. In what concerns cancer we can mention Farayola et al.39, that simulated a radiotherapy cancer treatment process with radiobiological factors, and Valentim et al.40, that propose a multistep exponential model with a fractional variable-order representing the evolution history of a tumor.

The Legendre polynomials are useful mathematical tools in fractional calculus. Cao et al.41 proposed a numerical algorithm based on the shifted Legendre polynomials to solve the fractional governing equations of polymethyl methacrylate in the time-domain. Zhijun et al.42 derived the operational matrix of fractional integration for Legendre polynomials to solve initial value problems of nonlinear fractional differential equations. Wang and Chen43 used the shifted Legendre polynomials for the dynamic analysis of viscoelastic pipes conveying fluid with variable order fractional model. Xiao et al.44 presented a finite-time empirical Gramians, constructed from impulse responses by solving block tridiagonal linear systems, to generate an approximate balanced model. Sun et al.45 designed an algorithm based on improved Legendre orthonormal basis for solving second-order boundary value problems. Hesameddini and Shahbazi46 approximated the unknown functions based on the two-dimensional shifted Legendre polynomials operational matrix method for the numerical solution of two-dimensional fractional integral equations. Guorong et al.47 proposed the Legendre orthogonal polynomials to calculate the acoustic reflection and transmission coefficients at liquid/solid interfaces. Singh et al.48 obtained numerical algorithms by using the Legendre, Galerkin and Legendre wavelet collocation methods for solving one phase moving boundary problem with conduction and convection effects. Rakhshan and Effati49 developed the generalized Legendre polynomials and derived a general procedure for solving nonlinear autonomous fractional differential equations with time varying delay. Heydari et al.50 presented a numerical method based on the discrete Legendre polynomials and the collocation scheme for solving nonlinear space-time fractional KdV-Burgers-Kuramoto equation. Kuznetsov51 used the Legendre polynomials and trigonometric functions for the numerical solution of the Ito stochastic differential equations when approximating multiple Ito and Stratonovich stochastic integrals based on generalized multiple Fourier series. Dehghan52 considered the shifted Legendre polynomials for class of variable order fractional functional boundary value problems.

In this work, an optimization method based on the generalized shifted Legendre polynomials (GSLP), operational matrix of derivatives and Lagrange multipliers is proposed for solving a fractional order breast cancer competition model (F-BCCM). The algorithm transforms the problem into a system of nonlinear algebraic equations with unknown coefficients, parameters and Lagrange multipliers. The optimal solution of the problem is obtained by solving an algebraic system of nonlinear equations. The results show that we can achieve the approximate solutions by employing only a few number of the basis functions. Moreover, the proposed approach can be adopted for solving other classes of fractional order problems.

The rest of the paper is structured as follows. Section 2 formulates the F-BCCM and the mathematical concept of fractional order Caputo derivative (F-CD). Section 3 discusses the shifted Legendre polynomials (SLP), as well as the GSLP and its operational matrix of derivatives and function approximation. Section 4 addresses the convergence analysis of the proposed method. Section 5 describes the method for finding the solution of the proposed problem. Section 6 discusses several illustrative examples. Section 7 analyses the epidemiologic and clinical relevance of the problem. Finally, Section 8 gives the main conclusions.

Fractional order breast cancer competition model

The mathematical theory and concepts adressing the evolution of diseases and epidemics have been advanced during the last decades. Usually, these formulations consider that all people in a community starts as healthy and that later some of them may be diagnosed with breast (cancer). Abernathy et al.19 described the dynamic behavior of giving up BCCM. The model was discussed analytically and considering cancer stem cells (C), tumor cells (T), healthy cells (H), immune cells (I), and excess strogen (E). The proposed model is given as

dC(t)dt=k1C(t)1-C(t)M1-γ1I(t)C(t)+p1C(t)E(t)a1+C(t),dT(t)dt=k2C(t)C(t)M11-T(t)M2-n1T(t)-γ2I(t)C(t)+p2T(t)E(t)a2+T(t),dH(t)dt=qH(t)1-H(t)M3-δH(t)T(t)-p3H(t)E(t)a3+H(t),dI(t)dt=s+ρI(t)T(t)ω+T(t)-γ3I(t)T(t)-n2I(t)-uI(t)E(t)v+E(t),dE(t)dt=τ-μ+d1C(t)a1+C(t)+d2T(t)a2+T(t)+d3H(t)a3+H(t)E(t),C0(t)=C(0),T0(t)=T(0),H0(t)=H(0),I0(t)=I(0),E0(t)=E(0). 2.1

In Table 1, we list the description and baseline values of the parameters in the system (2.1).

Table 1.

The parameters of the BCCM model.

Parameters Description Value
k1 Normal rate of division for C cells 0.75 day-1
k2 Normal rate of division for T cells 0.514 day-1
q Normal rate of division for H cells 0.70 day-1
M1 Carrying capacity of C cells 2.27×106 cells
M2 Carrying capacity of T cells 2.27×107 cells
M3 Carrying capacity of H cells 2.5×107 cells
γ1 Cancer stem cell death rate due to immune cell response 3×10-7 cell-1 day-1
γ2 Tumor cell death rate due to immune cell response 3×10-6 cell-1 day-1
γ3 Immune cell death rate due to tumor cell response 1×10-7 cell-1 day-1
p1 Rate at which estrogen helps to proliferate cancer stem cells 600 cell day-1 (pg/mL)-1
p2 Rate at which estrogen helps to proliferate tumor cells 0 cell day-1 (pg/mL)-1
p3 Rate at which healthy cells are lost to DNA mutation by estrogen presence 100 cell day-1 (pg/mL)-1
a1 Number of C cells at which the rate of absorption is at half its maximum 12M1 cells
a2 Number of T cells at which the rate of absorption is at half its maximum 12M2 cells
a3 Number of H cells at which the rate of absorption is at half its maximum 12M3 cells
n1 Normal death rate of tumor cells 0.01 day-1
n2 Normal death rate of immune cells 0.29 day-1
δ Healthy cell death rate due to competition with tumor cells 6×10-8 day-1 cell-1
s Source rate of immune cells 1.3×104 cell day-1
ρ Immune cell response rate 0.20 day-1
ω Immune cell threshold 3×105 cells
u Rate of immune suppression by estrogen 0.20 day-1
v Estrogen threshold 400 pg mL-1
τ Continuous infusion of estrogen 2000 pg mL-1 day-1
μ Washout rate of estrogen by the body 0.97 day-1
d1 Absorption rate of estrogen by cancer stem cells 0.01 day-1
d2 Absorption rate of estrogen by tumor cells 0.01 day-1
d3 Absorption rate of estrogen by healthy cells 0.01 day-1

This paper formulates an alternative representation of the BCCM considering the F-CD. The F-CD of order 0<η1, with respect to t is given by53,54:

0CDtηf(t)=1Γ1-η0tt-ξ-ηf(ξ)dξ,0<η<1,df(t)dt,η=1, 2.2

where Γ(·) denotes the Gamma function Γ(z)=0tz-1e-tdt,z>0. In expression (2.2), the convolution integral represents the memory effect embedded in the fractional derivative. Indeed, the fractional derivative uses the previous values of f(t), and captures the long memory effect of the dynamics. From (2.2), for any rN, we can write

0CDtηtr=Γ(r+1)Γ(r-η+1)tr-η,r=1,2,,0,r=0. 2.3

Rewriting the model (2.1) in terms of the F-CD, we obtain

0CDtη1C(t)=k1C(t)1-C(t)M1-γ1I(t)C(t)+p1C(t)E(t)a1+C(t),0CDtη2T(t)=k2C(t)C(t)M11-T(t)M2-n1T(t)-γ2I(t)C(t)+p2T(t)E(t)a2+T(t),0CDtη3H(t)=qH(t)1-H(t)M3-δH(t)T(t)-p3H(t)E(t)a3+H(t),0CDtη4I(t)=s+ρI(t)T(t)ω+T(t)-γ3I(t)T(t)-n2I(t)-uI(t)E(t)v+E(t),0CDtη5E(t)=τ-μ+d1C(t)a1+C(t)+d2T(t)a2+T(t)+d3H(t)a3+H(t)E(t),C0(t)=C(0),T0(t)=T(0),H0(t)=H(0),I0(t)=I(0),E0(t)=E(0), 2.4

where 0CDtηi, i=1,2,3,4,5, represents the F-CD of order 0<ηi1.

We must note that the dimension of the left-side equations of model (2.4) is (time)-ηi, i=1,2,3,4,5. Nonetheless, a close inspection of the right-hand sides shows that the quantities k1, k2, q, γ1, γ2, γ3, p1, p2, p3, n1, n2, δ, s, ρ, u, τ, μ, d1, d2 and d3 have the dimension (time)-1 and, therefore, we need to modify the right-hand sides to match the dimensions. The most straightforward way of doing this gives the following model

0CDtη1C(t)=k1η1C(t)1-C(t)M1-γ1η1I(t)C(t)+p1η1C(t)E(t)a1+C(t),0CDtη2T(t)=k2η2C(t)C(t)M11-T(t)M2-n1η2T(t)-γ2η2I(t)C(t)+p2η2T(t)E(t)a2+T(t),0CDtη3H(t)=qη3H(t)1-H(t)M3-δη3H(t)T(t)-p3η3H(t)E(t)a3+H(t),0CDtη4I(t)=sη4+ρη4I(t)T(t)ω+T(t)-γ3η4I(t)T(t)-n2η4I(t)-uη4I(t)E(t)v+E(t),0CDtη5E(t)=τη5-μη5+d1η5C(t)a1+C(t)+d2η5T(t)a2+T(t)+d3η5H(t)a3+H(t)E(t),C0(t)=C(0),T0(t)=T(0),H0(t)=H(0),I0(t)=I(0),E0(t)=E(0). 2.5

This is the system that we will actually use for modeling our problem. Note that in the limit case ηi1, i=1,2,3,4,5, the system (2.5) reduces to classical one (2.1)55,56.

Basis functions

Hereafter, we introduce two classes of the basis functions, namelly the SLP and GSLP, which will be used in approximating solutions of the F-BCCM (2.4).

Approximation by the shifted Legendre polynomials

The Legendre polynomials, defined on the interval [-1,1], can be determined with the recurrence formula

Pj+1(t)=2j+1j+1tPj(t)-jj+1Pj-1(t),j=1,2,, 3.1

where P0(t)=1 and P1(t)=t. To use Legendre polynomials in the interval [0, 1] we have to define the SLP by means of the change of variable t2t-1. The SLP, Pj(2t-1), can be denoted by Lj(t). Therefore, Lj(t) follows the relationship:

Lj+1(t)=(2j+1)(2t-1)j+1Lj(t)-jj+1Lj-1(t),j=1,2,, 3.2

where L0(t)=1 and L1(t)=2t-1. The analytical form of the SLP of degree j, Lj(t), is given by:

Lj(t)=k=0j(-1)j+k(j+k)!(j-k)!tk(k!)2. 3.3

Note that Lj(0)=(-1)j and Lj(1)=1.

A given function g(t) can be expressed using the SLP as follows

g(t)=RTQn(t)=RTPΦn(t), 3.4

where Qn(t) is an (n+1)-order column vector including the basis functions. The following selections for RT and Qn(t) are considered as

RT=[r0r1rn],P=p0,0p0,1p0,np1,0p1,1q1,npn,0pn,1pn,n,Φn(t)=[1tt2tn]T, 3.5

and

pij=(-1)i+j(i+j)!(i-j)!(j!)2,ij,0,i<j,i,j=0,1,,n. 3.6

Approximation by the generalized shifted Legendre polynomials

Let us define a set of basis functions based on the GSLP to obtain an efficient solution of (2.4). For mN, the GSLP, Lm(t), are constructed through a change of variable. Therefore, ti is transformed into ti+αi, i+αi>0, in the SLP and are defined by

Lm(t)=i=0m(-1)n+i(n+i)!(n-i)!ti+αi(i!)2, 3.7

where αi denotes the control parameters. If αi=0, then the GSLP coincide with the classical SLP.

By using the GSLP, the functions C(t), T(t), H(t), I(t) and E(t) can be expressed in the following form:

C(t)=ATQ1Ψ1(t),T(t)=BTQ2Ψ2(t),H(t)=CTQ3Ψ3(t),I(t)=DTQ4Ψ4(t),E(t)=ETQ5Ψ5(t), 3.8

where

Q1=1000q1,01q1,11q1,21q1,m11q2,01q2,11q2,21q2,m11qm1,01qm1,11qm1,21qm1,m11,Q2=1000q1,02q1,12q1,22q1,m22q2,02q2,12q2,22q2,m22qm2,02qm2,12qm2,22qm2,m22, 3.9
Q3=1000q1,03q1,13q1,23q1,m33q2,03q2,13q2,23q2,m33qm3,03qm3,13qm3,23qm3,m33,Q4=1000q1,04q1,14q1,24q1,m44q2,04q2,14q2,24q2,m44qm4,04qm4,14qm4,24qm4,m44, 3.10
Q5=1000q1,05q1,15q1,25q1,m55q2,05q2,15q2,25q2,m55qm5,05qm5,15qm5,25qm5,m55, 3.11
AT=[a0a1am1],BT=[b0b1bm2],CT=[c0c1cm3],DT=[d0d1dm4],ET=[e0e1em5],Ψ1(t)[ψ01(t)ψ11(t)ψm11(t)]T,Ψ2(t)[ψ02(t)ψ22(t)ψm22(t)]T,Ψ3(t)[ψ03(t)ψ13(t)ψm33(t)]T,Ψ4(t)[ψ04(t)ψ24(t)ψm44(t)]T,Ψ5(t)[ψ05(t)ψ15(t)ψm55(t)]T 3.12

and

qkji=(-1)k+j(k+j)!(k-j)!(j!)2,kj,0,k<j,k=1,2,,mi,j=0,1,,mi,i=1,2,,5, 3.13
ψji(t)=1,j=0,tj+αji,j=1,2,,mi,i=1,2,,5, 3.14

with αji standing for the control parameters.

The ηi-th F-CD of Ψi(t),i=1,2,,5, is given by

0CDtηiΨi(t)=DtηiΨi(t), 3.15

where Dtηi (the operational matrix of F-CD of order ηi) is as follows

Dtηi=t-ηi00000Γ2+α1iΓ2-ηi+α1i0000Γ3+α2iΓ3-ηi+α2i0000Γmi+1+αmiiΓmi+1-ηi+αmii. 3.16

Function approximation

Let us consider X=L2[0,1]. We introduce

Ym1=span{1L1(t)L2(t)Lm1(t)}.

Let u(t)Ym1 be the best approximation of u(t). Therefore, we have

vYm1,u-u2u-v2.

Since uYm1, there exist the unique coefficients AT=[a0a1am1], such that

A(t)u(t)=ATQ1Ψ1(t),

where Q1 and Ψ1(t) are defined in Eqs. (3.9) and (3.12).

Convergence analysis

The classical Weierstrass theorem (see57, Theorem 7.26) states that polynomials are dense in C(I), the space of all continuous complex functions on the closed interval I=[0,1] with the supremum norm. In other words, the set of all finite linear combinations of the functions

1,t,t2,t3,, 4.1

is dense in C(I). This can be expressed by saying that the functions (4.1) span C(I). The following question arises naturally, namely, if 0<λ1<λ2<, under what conditions, then is it true that the functions

1,tλ1,tλ2,, 4.2

span C(I)? The neat answer is that the functions (4.2) span C(I) if and only if n=11λn=.

Theorem 1

(The Müntz-Szasz Theorem):58 Suppose that 0<λ1<λ2< and let X be the closure in C(I) of the set of all finite linear combinations of the functions

1,tλ1,tλ2,. 4.3
  1. If n=11λn=, then X=C(I).

  2. If n=11λn< and if λ{λn}nN, λ0, then X does not contain the function tλn.

Remark 1

Let Cλ(I)C(I) be the set of all finite linear combinations of the functions defined in (4.2), where 0<λ1<λ2< and let Cβ(I) be the set of the functions

1,t1+β1,t2+β2,t3+β3,,ti+βi,, 4.4

where {βi}iN is a sequence of real numbers, with i+βi0 for all iN. It is obvious that Cλ(I)Cβ(I) and, hence, Cλ(I)¯Cβ(I)¯, where Cλ(I)¯ and Cβ(I)¯ are the closures of the sets Cλ(I) and Cβ(I) in C(I), respectively. In view of Theorem 1, it is apparent that the set Cβ(I) is dense in C(I), i.e., Cλ(I)¯=C(I).

Similarly, if Cγ(I) is the set of set of all finite linear combinations of the functions

1,-(n+1)!(n-1)(1!)2t1+γ1,(n+2)!(n-2)(2!)2t2+γ2,-(n+3)!(n-3)(3!)2t3+γ3,,(-1)n+i(n+i)!(n-i)(i!)2ti+γi,, 4.5

where {γi}iN is a sequence of real numbers, with i+γi0 for all iN, then, in view of Theorem 1, the set Cγ(I) is dense in C(I), i.e., Cγ(I)¯=C(I).

The following two theorems are immediate consequences of Theorem 1 and, therefore, we omit the details.

Theorem 2

Suppose that 0<1+β1<2+β2< and let Cβ(I) be the set of all finite linear combinations of the functions defined in (4.4).

  1. If n=11n+βn=, then Y:=Cβ(I)¯=C(I), where Cβ(I)¯ is the closure of the set Cβ(I) in C(I).

  2. If n=11n+βn<, and if β{βn}nN, β0, then Y does not contain the function tβn.

Theorem 3

Suppose that 0<1+γ1<2+γ2< and let Cγ(I) be the set of all finite linear combinations of the functions defined in (4.5).

  1. If n=11n+γn=, then Z:=Cγ(I)¯=C(I), where Cγ(I)¯ is the closure of the set Cγ(I) in C(I).

  2. If n=11n+γn<, and if γ{γn}nN, γ0, then Z does not contain the function tγn.

We now investigate the convergence of the proposed method. We first discuss the convergence analysis of the GP expansion by means of the following theorem.

Theorem 4

Let f:[0,1]R be a continuous function. Then, for every ϵ>0 there exists a generalized polynomials59, Pm1(t), such that

f-Pm1=sup{|f(t)-Pm1(t)|:t[0,1]}<ϵ.

Proof

Let ϵ>0 be a fixed real number. Chose a sequence {βi}iN of real numbers with i+βi0, 0<i+βi<i+1+βi+1 for all iN and n=11n+βn=. Applying Theorem 1, we get the desired result. This completes the proof.

For discussing the convergence analysis of the GSLP expansion we consider the following theorem.

Theorem 5

Let f:[0,1]R be a continuous function. Then, for every ϵ>0, there exists a GSLP, Lm1(t), such that

f-Lm1=sup{|f(t)-Lm1(t)|:t[0,1]}<ϵ.

Proof

Let ϵ>0 be a fixed real number. Chose a sequence {γi}iN of real numbers with i+γi0, 0<i+γi<i+1+γi+1 for all iN and n=11n+γn=. Applying Theorem 1, we get the desired result. This completes the proof.

The proposed strategy

In this section, we design a matrix approach by using the GSLP to solve the problem generated in Eq. (2.5). To carry out this method, we approximate C(t), T(t), H(t), I(t) and E(t) by the GSLP basis as follows

C(t)=ATQ1Ψ1(t),T(t)=BTQ2Ψ2(t),H(t)=CTQ3Ψ3(t),I(t)=DTQ4Ψ4(t),E(t)=ETQ5Ψ5(t), 5.1

where AT, BT, CT, DT, ET and Φi=α1iα2iαmii, i=1,2,3,4,5, are undetermined vectors including the free coefficients and control parameters, and Qi and Ψi(t), i=1,2,3,4,5, are defined in Eqs. (3.93.14). Regarding (3.16), one has

0CDtη1C(t)=ATQ1Dtη1Ψ1(t),0CDtη2T(t)=BTQ2Dtη2Ψ2(t),0CDtη3H(t)=CTQ3Dtη3Ψ3(t),0CDtη4I(t)=DTQ4Dtη4Ψ4(t),0CDtη5E(t)=ETQ5Dtη5Ψ5(t). 5.2

Moreover, we approximate the initial conditions given in Eq. (2.5) via the GSLP as follows

C(0)ATQ1Ψ1(0),T(0)BTQ2Ψ2(0),H(0)CTQ3Ψ3(0),I(0)DTQ4Ψ4(0),E(0)ETQ5Ψ5(0). 5.3

Now, we define the residual function by using Eq. (2.5) and Eqs. (5.15.2), so that

R1(t)=ATQ1Dtη1Ψ1(t)-k1η1ATQ1Ψ1(t)1-ATQ1Ψ1(t)M1+γ1η1DTQ4Ψ4(t)ATQ1Ψ1(t)-p1η1ATQ1Ψ1(t)ETQ5Ψ5(t)a1+ATQ1Ψ1(t),R2(t)=BTQ2Dtη2Ψ2(t)-k2η2ATQ1Ψ1(t)ATQ1Ψ1(t)M11-BTQ2Ψ2(t)M2+n1η2BTQ2Ψ2(t)+γ2η2DTQ4Ψ4(t)ATQ1Ψ1(t)-p2η2BTQ2Ψ2(t)ETQ5Ψ5(t)a2+BTQ2Ψ2(t),R3(t)=CTQ3Dtη3Ψ3(t)-qη3CTQ3Ψ3(t)1-CTQ3Ψ3(t)M3+δη3CTQ3Ψ3(t)BTQ2Ψ2(t)+p3η3CTQ3Ψ3(t)ETQ5Ψ5(t)a3+CTQ3Ψ3(t),R4(t)=DTQ4Dtη4Ψ4(t)-sη4-ρη4DTQ4Ψ4(t)BTQ2Ψ2(t)ω+BTQ2Ψ2(t)+γ3η4DTQ4Ψ4(t)BTQ2Ψ2(t)+n2η4DTQ4Ψ4(t)+uη4DTQ4Ψ4(t)ETQ5Ψ5(t)v+ETQ5Ψ5(t),R5(t)=ETQ5Dtη5Ψ5(t)-τη5+μη5+d1η5ATQ1Ψ1(t)a1+ATQ1Ψ1(t)+d2η5BTQ2Ψ2(t)a2+BTQ2Ψ2(t)+d3η5CTQ3Ψ3(t)a3+CTQ3Ψ3(t)ETQ5Ψ5(t). 5.4

Meanwhile, from Eqs. (2.5) and (5.3), we have

ATQ1Ψ1(0)-C(0)Θ10,BTQ2Ψ2(0)-T(0)Θ20,CTQ3Ψ3(0)-H(0)Θ30,DTQ4Ψ4(0)-I(0)Θ40,ETQ5Ψ5(0)-E(0)Θ50. 5.5

We can generate the 2-norm of the residual functions as

M(Q1,Q2,Q3,Q4,Q5,Φi)=0k(R12+R22+R32+R42+R52)(t)dt, 5.6

where Qi and Φi, i=1,2,,5, are the free coefficients and control parameters, respectively.

To obtain the optimal values for the free coefficients and control parameters, we consider the following optimization problem

minM(Q1,Q2,Q3,Q4,Q5,Φi), 5.7

subject to Eq. (5.5), where M is the objective function.

To solve this minimization problem, we assume that

J[Q1,Q2,Q3,Q4,Q5,Φi,λ]=M(B1,B2,B3,B4,B5,Φi)+λΘ, 5.8

where λ denotes unknown Lagrange multipliers.

In order to obtain the extremum, the necessary conditions are:

Jλ=0,JQi=0,JΦi=0,i=0,1,,5. 5.9

Finally, by solving Eq. (5.9) using a software package to calculate the components Q1, Q2, Q3, Q4, Q5, Φi and λ, we obtain the approximate solutions C(t), T(t), H(t), I(t) and E(t) of Eq. (3.5). In this study we used Maple 18 (with 20 digits precision) for the above extracted system and also for all numerical simulations. The step-by-step algorithm of the new technique is summarised as follows: graphic file with name 41598_2021_94875_Figa_HTML.jpg

Numerical simulations

In this section, two examples are considered to illustrate the applicability of the proposed technique when solving the F-BCCM (2.5). The numerical simulations are based on the packages Maple 18 (with accuracy 40 decimal digits) and Matlab.

Example 1

Consider the F-BCCM (2.5) and the parameters listed in Table 1. The algorithm is used to solve the F-BCCM (2.5) with C(0)=7.3710×105, T(0)=7.6167×106, H(0)=2.5000×107, I(0)=0 and E(0)=0, for different values of ηi and mi, i=1,2,3,4,5. The approximate solutions of the five state variables {C(t),T(t),H(t),I(t),E(t)}, with m1=2, m2=m3=m4=3, m5=4, for η1=0.10, η2=0.15, η3=0.20, η4=0.25, η5=0.30 and also η1=0.98, η2=0.99, η3=0.97, η4=0.98, η5=0.99 are shown in Figs. 1 and 2, respectively. The plots of the approximate solutions with m1=3, m2=m3=m4=4, m5=5 for η1=0.10, η2=0.15, η3=0.20, η4=0.25, η5=0.30 and also η1=0.98, η2=0.99, η3=0.97, η4=0.98, η5=0.99 are illustrated in Figs. 3 and 4, respectively. The runtime of the proposed method and the optimal values of the residual function with different choices of mi, i=1,2,3,4,5 are reported in Tables 2 and 3, respectively. According to Figs. 1, 2, 3, 4, the number of cancer stem and tumor cells and estrogen, C, T and E, decreases, while the healthy and immune cells, H and I, increase. This effect is associated with better prognosis and longer patient survival. The obtained results with the proposed method provide a meaningful solution by applying even a small number of basis functions. From Table 2 we verify that if we select large values of mi, i=1,2,3,4,5, then we pose an higher computational load.

Figure 1.

Figure 1

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=2, m2=m3=m4=3, m5=4, η1=0.10, η2=0.15, η3=0.20, η4=0.25 and η5=0.30 for Example 1.

Figure 2.

Figure 2

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=2, m2=m3=m4=3, m5=4, η1=0.98, η2=0.99, η3=0.97, η4=0.98 and η5=0.99 for Example 1.

Figure 3.

Figure 3

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=3, m2=m3=m4=4 and m5=5, η1=0.10, η2=0.15, η3=0.20, η4=0.25 and η5=0.30 for Example 1.

Figure 4.

Figure 4

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=3, m2=m3=m4=4 and m5=5, η1=0.98, η2=0.99, η3=0.97, η4=0.98 and η5=0.99 for Example 1.

Table 2.

The runtime (in seconds) of the proposed method with different choices of mi, i=1,2,3,4,5, for Example 1.

Case m1 m2 m3 m4 m5 CPU time CPU time
η1=0.10,η2=0.15,η3=0.20,η4=0.25,η5=0.30 η1=0.98,η2=0.99,η3=0.97,η4=0.98,η5=0.99
1 2 3 3 3 4 15.23 15.29
2 3 4 4 4 5 19.74 19.76

Table 3.

The optimal values of the residual function with different values of mi, i=1,2,3,4,5, for Example 1.

Case m1 m2 m3 m4 m5 Residual function Residual function
η1=0.10,η2=0.15,η3=0.20,η4=0.25,η5=0.30 η1=0.98,η2=0.99,η3=0.97,η4=0.98,η5=0.99
1 2 3 3 3 4 7.4167E-07 2.9968E-07
2 3 4 4 4 5 8.2858E-08 7.4587E-09

Example 2

Let us consider the F-BCCM (2.5) and the parameters values given in Table 1. We consider C(0)=7.3710×105, T(0)=7.6167×106, H(0)=2.5000×107, I(0)=0 and E(0)=0 for different values of ηi and mi, i=1,2,3,4,5. The new method is applied to obtain the numerical solution of the F-BCCM (2.5). The approximate solutions of the five state variables {C(t),T(t),H(t),I(t),E(t)} with m1=m2=4, m3=5 and m4=m5=7 for η1=0.08, η2=0.17, η3=0.13, η4=0.11, η5=0.23 and also η1=0.96, η2=0.98, η3=0.99, η4=0.96, η5=0.95 are shown in Figs. 5 and 6, respectively. The plots of the approximate solutions with m1=m2=m3=6, m4=m5=8 for η1=0.08, η2=0.17, η3=0.13, η4=0.11, η5=0.23 and also η1=0.96, η2=0.98, η3=0.99, η4=0.96, η5=0.95 are illustrated in Figs. 7 and 8, respectively. The runtime of the proposed method and the optimal values of the residual function with different choices of mi, i=1,2,3,4,5, are reported in Tables 4 and 5, respectively. According to Figs. 5, 6, 7, 8, the number of cancer stem and tumor cells and estrogen, C, T and E, decreases, while the healthy and immune cells, H and I, increase. This effect is associated with better prognosis and longer patient survival. Also, from Table 4 we conclude that if we choose large values of mi, i=1,2,3,4,5, then leads to an higher computational load.

Figure 5.

Figure 5

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=m2=4, m3=5, m4=m5=7, η1=0.08, η2=0.17, η3=0.13, η4=0.11 and η5=0.23 for Example 2.

Figure 6.

Figure 6

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=m2=4, m3=5, m4=m5=7, η1=0.96, η2=0.98, η3=0.99, η4=0.96 and η5=0.95 for Example 2.

Figure 7.

Figure 7

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=m2=m3=6, m4=m5=8, η1=0.08, η2=0.17, η3=0.13, η4=0.11 and η5=0.23 for Example 2.

Figure 8.

Figure 8

Evolution of {C(t),T(t),H(t),I(t),E(t)} vs time for the F-BCCM with m1=m2=m3=6, m4=m5=8, η1=0.96, η2=0.98, η3=0.99, η4=0.96 and η5=0.95 for Example 2.

Table 4.

The runtime (in seconds) of the proposed method with different choices of mi, i=1,2,3,4,5, for Example 2.

Case m1 m2 m3 m4 m5 CPU time CPU time
η1=0.08,η2=0.17,η3=0.13,η4=0.11,η5=0.23 η1=0.96,η2=0.98,η3=0.99,η4=0.96,η5=0.95
1 4 4 5 7 7 26.41 26.43
2 6 6 6 8 8 35.08 35.18

Table 5.

The optimal values of the residual function with different choices of mi, i=1,2,3,4,5, for Example 2.

Case m1 m2 m3 m4 m5 Residual function Residual function
η1=0.08,η2=0.17,η3=0.13,η4=0.11,η5=0.23 η1=0.96,η2=0.98,η3=0.99,η4=0.96,η5=0.95
1 4 4 5 7 7 3.9316E-11 4.8842E-12
2 6 6 6 8 8 8.0023E-14 1.1164E-14

Remark 2

Abernathy et al.19 presented a system of five ordinary differential equations which consider the population dynamics among cancer stem, tumor, and healthy cells. They described (i) the effects of excess estrogen and the body’s natural immune response on the aforementioned cell populations and (ii) the global dynamics of the F-BCCM (2.5), with ηi=1, i=1,2,3,4,5, along with various submodels by employing a variety of analytical methods. In this paper we consider the integer order model (2.1) proposed initially in19 and generalize it to fractional order (2.5). Additionally, we introduced a new basis function (i.e., the GSLP) for solving the F-BCCM (2.5) and obtained optimally the unknoun coefficients and parameters. From the results we verify not only that the approximation by the new method provides good approximate solutions, but also that it is superior to the one proposed by Abernathy et al.19.

Epidemiologic and clinical relevance

Tumor cells proliferate abnormally and gradually undergo changes that induce the growth and development of cancer with an high mutation rate and spread, leading to tumor progression. A small number of cancer stem cells can be the source of cancer and cause recurrence, metastasis and resistance to treatment. Presently, stem cells are being targeted for cancer treatment, so that with a lower number of cancer cell we can expect better prognosis. On the other hand, healthy cells must exhibit a normal proliferation and function. In other words, they do not undergo aberrant proliferation and malignant changes. Immune cells play a key role in defending the body against foreign agents and deformed cells such as those of cancer. An high number of immune cells, in particular of T lymphocytes, correlates with a better prognosis for the patient. Epidemiological studies revealed the pivotal role of estrogen in the initiation and progression of breast cancer60. The hormone has also influence in the mechanism of some drugs for treatment, since they inhibit estrogen and the duration of exposure to the estrogen increases the risk of breast cancer6163. During the progression of the breast cancer there are evidences that an increasing number of immune cell infiltrate in tumor parenchyma, including the cytotoxic CD8+ T, CD4+ T helper, B, macrophages and dendritic cells, the natural killer cells, and cytokines, such as interferons, interleukins, chemokines and growth factors64,65. Immune cells contain estrogen receptors and are regulated by estrogens as well. Therefore, strogens could influence immune cells in breast cancer64. Parenchymal and stromal cells of breast may be accessible to several immune cells subtypes that lead to decreasing the tumor cells and reducing tumor growth64. Therefore, from the medical point of view, the numerical results show that the approximate solution is coherent with real-word experience.

From the numerical viewpoint, we must highlight that there is a basic difference between the proposed approach and other spectral methods. In fact, the main idea of spectral methods (based on the Legendre, Chebyshev, Lagrange and Jacobi polynomials) is to express the solution of a differential equation as a sum of the basis functions and then to choose the coefficients in order to minimize the error between the numerical and exact solutions, in some suitable sense. To determine the coefficients, three main techniques, are commonly employed, namely the Galerkin, tau and collocation methods. In the present case, the residual function and its 2-norm are employed for converting the problem to an optimization one, so that the unknown parameters are obtained optimally. As a result, the necessary conditions of optimality are derived in the form of a system of nonlinear algebraic equations with unknown parameters. It is also worth mentioning that approximating any arbitrary smooth function by the eigenfunctions of singular Sturm-Liouville problems, such as the Legendre, Chebyshev, Hermite, Lagrange, Laguerre or Jacobi polynomials, has spectral accuracy. This means that the truncation error approaches zero faster than any negative power of the number of the basis functions used in the approximation, as that number tends to infinity. Consequently, these basis functions are not the most adequate for approximating non analytic functions, in contrast which occurs when using the GSLP which prove to be much more efficient.

Conclusion

This paper developed and analyzed the GSLP method for solving the F-BCCM. The proposed approach is based on the operational matrices of the GSLP and the Lagrange multipliers. By adopting the GSLP basis and operational matrices of F-CD, the problem was reduced to the solution of a system of algebraic equations. The convergence analysis for the new algorithm was also carried out. Two numerical examples illustrate the ability and reliability of the algorithm. This method shows that with fewer number of basis functions we can obtain the approximate the solutions. This model and algorithm can be further explored to develop in silico studies of the dynamics and cancer problems.

Author contributions

H.H.: Conceptualization, Methodology, Writing- Original draft preparation, Software, Investigation. J.A.T.M.: Investigation, Validation, Writing- Reviewing and Editing. Z.A.: Conceptualization, Methodology, Software, Validation, Investigation, Funding. E.S.: Investigation, Validation, Writing- Reviewing and Editing, S.M.: Investigation, Validation, Writing- Reviewing and Editing.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Vogelstein B, Kinzler KW. The Genetic Basis of Human Cancer. 1. New York: McGraw-Hill Companies; 1997. p. 744. [Google Scholar]
  • 2.Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat. Rev. Cancer. 2004;4(3):197–205. doi: 10.1038/nrc1295. [DOI] [PubMed] [Google Scholar]
  • 3.Bardelli A, et al. Carcinogen-specific induction of genetic instability. PNAS. 2001;98(10):5770–5775. doi: 10.1073/pnas.081082898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Leob LA. Microsatellite instability: Marker of a mutator phenotype in cancer. Cancer Res. 1994;54(19):5059–5063. [PubMed] [Google Scholar]
  • 5.Tomlinson I, Sasieni P, Bodmer W. How many mutations in a cancer. Am. J. Pathol. 2002;160(3):755–758. doi: 10.1016/S0002-9440(10)64896-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nat. Med. 1999;5(1):11–12. doi: 10.1038/4687. [DOI] [PubMed] [Google Scholar]
  • 7.Tomlinson IPM, Novelli MR, Bodmer WF. The mutateon rate and cancer. Proc. Natl. Acad. Sci. USA. 1996;93(25):1483–1490. doi: 10.1073/pnas.93.25.14800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Knudson AG., Jr Mutation and cancer: A statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 1971;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Moolgavka SH, Knudson AG., Jr Mutation and cancer: A model for numan carsinogenosis. J. Natl. Cancer Inst. 1981;66(6):1037–1052. doi: 10.1093/jnci/66.6.1037. [DOI] [PubMed] [Google Scholar]
  • 10.Cairns J. Mutation selection and the natural history of cancer. Nature. 1975;255:197–200. doi: 10.1038/255197a0. [DOI] [PubMed] [Google Scholar]
  • 11.Cairns J. Somatic stem cells and the kinetics of mutagensis and carsinogenesis. Proc. Natl. Acad. Sci. USA. 2002;99(16):10567–10570. doi: 10.1073/pnas.162369899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Frank SA, Nowak MA. Cell biology: Developmental predisposition to cancer. Nature. 2003;422:494. doi: 10.1038/422494a. [DOI] [PubMed] [Google Scholar]
  • 13.Frank SA, Iwasa Y, Nowak MA. Patterns of cell division and the risk of cancer. Genetics. 2003;163(4):1527–1532. doi: 10.1093/genetics/163.4.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Siegel RL, Miller KD, Jemal A. Cancer statistics, CA: A Cancer. J. Clin. 2020;70(1):7–30. doi: 10.3322/caac.21590. [DOI] [PubMed] [Google Scholar]
  • 15.Enderling H, et al. Mathematical modelling of radiotherapy strategies for early breast cancer. J. Theor. Biol. 2006;241(1):158–171. doi: 10.1016/j.jtbi.2005.11.015. [DOI] [PubMed] [Google Scholar]
  • 16.Enderling H, Chaplain MAJ, Anderson ARA, Vaidya JS. A mathematical model of breast cancer development, local treatment and recurrence. J. Theor. Biol. 2007;246(2):245–259. doi: 10.1016/j.jtbi.2006.12.010. [DOI] [PubMed] [Google Scholar]
  • 17.Simmons A, et al. Environmental factors in breast cancer invasion: A mathematical modelling review. Pathology. 2017;49(2):172–180. doi: 10.1016/j.pathol.2016.11.004. [DOI] [PubMed] [Google Scholar]
  • 18.Nave OP, Elbaz M, Bunimovich-Mendrazitsky S. Analysis of a breast cancer mathematical model by a new method to find an optimal protocol for HERT2-positive cancer. Biosystems. 2020;197:104191. doi: 10.1016/j.biosystems.2020.104191. [DOI] [PubMed] [Google Scholar]
  • 19.Abernathy K, Abernathy Z, Baxter A, Stevens M. Global dynamics of a breast cancer competition model. Differ. Equ. Dyn. Syst. 2017;1:1–15. doi: 10.1007/s12591-017-0346-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chen C, et al. Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer. J. R. Soc. Interface. 2014;11(96):1–11. doi: 10.1098/rsif.2014.0206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang Z, et al. Simulating cancer growth with multiscale agent-based modeling. Semin. Cancer Biol. 2015;30:70–78. doi: 10.1016/j.semcancer.2014.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barrea A, Hernández ME. Optimal control of a delayed breast cancer stem cells nonlinear model. Optim. Contr. Appl. Met. 2016;37(2):248–258. doi: 10.1002/oca.2164. [DOI] [Google Scholar]
  • 23.Jenner AL, Yun CO, Kim PS, Coster ACF. Mathematical modelling of the interaction between cancer cells and an oncolytic virus: Insights into the effects of treatment protocols. Bull. Math. Biol. 2018;80(6):1615–1629. doi: 10.1007/s11538-018-0424-4. [DOI] [PubMed] [Google Scholar]
  • 24.Weis JA, Miga MI, Yankeelov TE. Three-dimensional image-based mechanical modeling for predicting the response of breast cancer to neoadjuvant therapy. Comput. Methods Appl. Mech. Eng. 2017;314:494–512. doi: 10.1016/j.cma.2016.08.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lee AJ, et al. BOADICEA breast Cancer risk prediction model: Updates to Cancer incidences, tumour pathology and web interface. Br. J. Cancer. 2014;110(2):535–545. doi: 10.1038/bjc.2013.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Podlubny I. Fractional Differential Equations. New York: Academic Press; 1999. [Google Scholar]
  • 27.Miller KS, Ross B. An Introduction to the Fractional Calculus and Differential Equations. New York: John Wiley; 1993. [Google Scholar]
  • 28.Hilfer R. Applications of Fractional Calculus in Physics. Singapore: World Scientific; 2000. [Google Scholar]
  • 29.Agrawal OP, Tenreiro Machado JA, Sabatier J. Nonlinear Dynamics, Special Issue: Fractional Derivatives and Their Applications. Kluwer: Academic Publishers; 2004. [Google Scholar]
  • 30.Gaul L, Klein P, Kempfle S. Damping description involving fractional operators. Mech. Syst. Signal Pr. 1991;5(2):81–88. doi: 10.1016/0888-3270(91)90016-X. [DOI] [Google Scholar]
  • 31.Riewe F. Mechanics with fractional derivatives. Phys. Rev. E. 1997;55(3):3582–3592. doi: 10.1103/PhysRevE.55.3581. [DOI] [Google Scholar]
  • 32.Mainardi, F. Fractional calculus, Some basic problems in continuum and statistical mechanics, Fractals and Fractional Calculus in Continuum Mechanics. 291-348 (Springer-Verlag, Wien, 1997).
  • 33.Lorenzo CF, Hartley TT. Initialized fractional calculus. Int. J. Appl. Math. 2000;3(3):249–265. [Google Scholar]
  • 34.Sun H, Chen W, Wei H, Chen Y. A comparative study of constant-order and variable-order fractional models in characterizing memory property of systems. Eur. Phys. J. Spec. Top. 2011;193:185–192. doi: 10.1140/epjst/e2011-01390-6. [DOI] [Google Scholar]
  • 35.Glockle WG, Nonnenmacher TF. A fractional calculus approach of self-similar protein dynamics. Biophys. J. 1995;68(1):46–53. doi: 10.1016/S0006-3495(95)80157-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chen Y, Yi M, Chen C, Yu C. Bernstein polynomials method for fractional convection-diffusion equation with variable coefficients. CMES Comput. Model. Eng. Sci. 2012;83(6):639–654. [Google Scholar]
  • 37.Schneider WR, Wyss W. Fractional diffusion and wave equations. J. Math. Phys. 1989;30:134–144. doi: 10.1063/1.528578. [DOI] [Google Scholar]
  • 38.Boyadjiev L, Scherer R. Fractional extensions of the temperature field problem in oil strata. Kuwait J. Sci. Eng. 2004;31(2):15–32. [Google Scholar]
  • 39.Farayola MF, Shafie S, Siam FM, Khan I. Mathematical modeling of radiotherapy cancer treatment using Caputo fractional derivative. Comput. Meth. Prog. Bio. 2020;188:105306. doi: 10.1016/j.cmpb.2019.105306. [DOI] [PubMed] [Google Scholar]
  • 40.Valentim CA, Rabi JA, David SA, Tenreiro Machado JA. On multistep tumor growth models of fractional variable-order. Biosystems. 2021;199:104294. doi: 10.1016/j.biosystems.2020.104294. [DOI] [PubMed] [Google Scholar]
  • 41.Cao J, et al. Shifted Legendre polynomials algorithm used for the dynamic analysis of PMMA viscoelastic beam with an improved fractional model. Chaos Soliton. Fract. 2020 doi: 10.1016/j.chaos.2020.110342. [DOI] [Google Scholar]
  • 42.Zhijun M, Mingxu Y, Jun H, Lei S. Numerical solutions of nonlinear fractional differential equations by alternative Legendre polynomials. Appl. Math. Comput. 2018;336:454–464. [Google Scholar]
  • 43.Wang Y, Chen Y. Shifted Legendre Polynomials algorithm used for the dynamic analysis of viscoelastic pipes conveying fluid with variable fractional order model. Appl. Math. Modell. 2020;81:159–176. doi: 10.1016/j.apm.2019.12.011. [DOI] [Google Scholar]
  • 44.Xiao ZH, Jiang YL, Qi ZZ. Finite-time balanced truncation for linear systems via shifted Legendre polynomials. Syst. Control Lett. 2019;126:48–57. doi: 10.1016/j.sysconle.2019.03.004. [DOI] [Google Scholar]
  • 45.Sun H, Mei L, Lin Y. A new algorithm based on improved Legendre orthonormal basis for solving second-order BVPs. Appl. Math. Lett. 2021;112:106732. doi: 10.1016/j.aml.2020.106732. [DOI] [Google Scholar]
  • 46.Hesameddini E, Shahbazi M. Two-dimensional shifted Legendre polynomials operational matrix method for solving the two-dimensional integral equations of fractional order. Appl. Math. Comput. 2018;322:40–54. [Google Scholar]
  • 47.Guorong S, et al. Application of Legendre orthogonal polynomial method in calculating reflection and transmission coefficients of multilayer plates. Wave Motion. 2019;84:32–45. doi: 10.1016/j.wavemoti.2018.09.007. [DOI] [Google Scholar]
  • 48.Singh J, Jitendra G, Rai KN. Legendre wavelet based numerical solution of variable latent heat moving boundary problem. Math. Comput. Simulat. 2020;178:485–500. doi: 10.1016/j.matcom.2020.06.020. [DOI] [Google Scholar]
  • 49.Rakhshan SA, Effati S. A generalized Legendre-Gauss collocation method for solving nonlinear fractional differential equations with time varying delays. Appl. Numer. Math. 2019;146:342–360. doi: 10.1016/j.apnum.2019.07.016. [DOI] [Google Scholar]
  • 50.Heydari MH, Avazzadeh Z, Cattani C. Numerical solution of variable-order space-time fractional KdV-Burgers-Kuramoto equation by using discrete Legendre polynomials. Eng. Comput. 2020 doi: 10.1007/s00366-020-01181-x. [DOI] [Google Scholar]
  • 51.Kuznetsov DF. A comparative analysis of efficiency of using the legendre polynomials and trigonometric functions for the numerical solution of ito stochastic differential equations. Comput. Math. Math. Phys. 2019;59:1236–1250. doi: 10.1134/S0965542519080116. [DOI] [Google Scholar]
  • 52.Dehghan R. A numerical solution of variable order fractional functional differential equation based on the shifted Legendre polynomials. SeMA J. 2019;76:217–226. doi: 10.1007/s40324-018-0173-1. [DOI] [Google Scholar]
  • 53.Hassani H, Avazzadeh Z, Tenreiro Machado JA. Numerical approach for solving variable-order space-time fractional telegraph equation using transcendental Bernstein series. Eng. Comput. 2020;36:867–878. doi: 10.1007/s00366-019-00736-x. [DOI] [Google Scholar]
  • 54.Hassani H, Tenreiro Machado JA, Avazzadeh Z. An effective numerical method for solving nonlinear variable-order fractional functional boundary value problems through optimization technique. Nonlinear Dynam. 2019;97:2041–2054. doi: 10.1007/s11071-019-05095-2. [DOI] [Google Scholar]
  • 55.Diethelm K. A fractional calculus based model for the simulation of an outbreak of dengue fever. Nonlinear Dynam. 2013;71:613–619. doi: 10.1007/s11071-012-0475-2. [DOI] [Google Scholar]
  • 56.Rihan FA, Arafa AA, Rakkiyappan R, Rajivganthi C, Xu Y. Fractional-order delay differential equations for the dynamics of hepatitis C virus infection with IFN-α treatment. Alexandr. Eng. J. 2021;60:4761–4774. doi: 10.1016/j.aej.2021.03.057. [DOI] [Google Scholar]
  • 57.Kreyszig E. Introductory Functional Analysis with Applications. New York: John Wiley and Sons Inc.; 1978. [Google Scholar]
  • 58.Rudin W. Real and Complex Analysis. 3d. New York: McGraw-Hill Book Company; 1987. [Google Scholar]
  • 59.Dahaghin M, Hassani H. An optimization method based on the generalized polynomials for nonlinear variable-order time fractional diffusion-wave equation. Nonlinear Dynam. 2017;88(3):1587–1598. doi: 10.1007/s11071-017-3330-7. [DOI] [Google Scholar]
  • 60.Segovia-Mendoza M, Morales-Montor J. Immune tumor microenvironment in breast cancer and the participation of estrogen and its receptors in cancer physiopathology. Front. Immunol. 2019;10:348. doi: 10.3389/fimmu.2019.00348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Murphy LC, Leygue E. The role of estrogen receptor-β in breast cancer. Semin. Reprod. Med. 2012;30:5–13. doi: 10.1055/s-0031-1299592. [DOI] [PubMed] [Google Scholar]
  • 62.Waks AG, Winer EP. Breast cancer treatment: A review. JAMA Netw. 2019;321(3):288–300. doi: 10.1001/jama.2018.19323. [DOI] [PubMed] [Google Scholar]
  • 63.Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006;354:270–282. doi: 10.1056/NEJMra050776. [DOI] [PubMed] [Google Scholar]
  • 64.Goff SL, Danforth DN. The role of immune cells in breast tissue and immunotherapy for the treatment of breast cancer. Clin. Breast Cancer. 2020;21(1):e63–e73. doi: 10.1016/j.clbc.2020.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Galli F, Aguilera JV, Palermo B, Markovic SN, Nisticò P, Signore A. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. J. Exp. Clin. Cancer Res. 2020 doi: 10.1186/s13046-020-01586-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES